This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow non-healthcare professionals to attend Best Practice London

Co-located events

2024 Conference Programme


Diagnosis and management of MASLD (formerly NAFLD) in primary care including the management of abnormal liver blood tests

28 Feb 2024
Best Practice Clinical Theatre 1

Recent international consensus has led to the renaming of non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease (MASLD) to reduce stigma, improve patient identification and reflect that MASLD is primarily a metabolic condition and not a liver condition. MASLD encompasses individuals who have hepatic steatosis and at least one cardiometabolic risk factor. Metabolic dysfunction-associated steatohepatitis (MASH) replaces non-alcoholic steatohepatitis (NASH). This session will cover the screening, diagnosis and management of MASLD in primary care, including the interpretation of abnormal liver blood tests.

Kevin Fernando, GP with Specialist Interest in Diabetes/CVRM Medicine & Medical Education - North Berwick Health Centre

Newsletter Sign Up